Platelet-rich plasma for androgenetic alopecia: A pilot study

Dermatologic Surgery

Volumn 40, Issue 9, 2014, Pages 1010-1019

  Schiavone, Giovanni ^a   Raskovic, Desanka ^a   Greco, Joseph ^b   Abeni, Damiano ^a  

^a LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

^b Hair Restoration Surgery Greco Medical Group   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALOPECIA; CYTOKINES; FEMALE; HUMANS; LEUKOCYTES; MALE; PHOTOGRAPHY; PILOT PROJECTS; PLATELET-DERIVED GROWTH FACTOR; PLATELET-RICH PLASMA; SCALP; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84906813938     PISSN: 10760512     EISSN: 15244725     Source Type: Journal    
DOI: 10.1097/01.DSS.0000452629.76339.2b     Document Type: Article

References (47)

1. Tabolli S, Sampogna F, di Pietro C, Mannooranparampil TJ, et al. Health status, coping strategies, and alexithymia in subjects with androgenetic alopecia: a questionnaire study. Am J Clin Dermatol 2013; 14: 139-45.
2. Sampogna F, Tabolli S, Abeni D. Impact of different skin conditions on quality of life. G Ital Dermatol Venereol 2013; 148: 255-61.
3. Paus R. Do we need hair follicle stem cells, hair follicle neogenesis to cure common hair loss disorders? Hair Transplant Forum Int'l 2008; 18: 89-90.
4. Fuchs E. Scratching the surface of skin development. Nature 2007; 445: 834-42.
5. Akiyama M, Smith LT, Holbrook KA. Growth factor and growth factor receptor localization in hair follicle bulge and associated tissue in human fetus. J Invest Dermatol 1996; 106: 391-6. (Pubitemid 26117580)
6. Lucarelli E, Beccheroni A, Donati D, Sangiorgio L, et al. Platelet-derived growth factors enhance proliferation of human stromal stem cells. Biomaterials 2003; 24: 3095.
7. Kamp H, Geilen CC, Sommer C, Blume-Peytavi U. Regulation of PDGF and PDGF receptor in cultured dermal papilla cells and follicular keratinocytes of human hair follicle. Exp Dermatol 2003; 12: 662-72. (Pubitemid 37270729)
8. Takakura N, Yoshida H, Kunisada T, Nishikawa S, et al. Involvement of platelet derived growth factor receptor-a in hair canal formation. J Invest Dermatol 1996; 107: 770-7. (Pubitemid 26371096)
9. Yano K, Brown L, Detmar M. Control of hair growth and follicle size by VEGF-mediated angiogenesis. J Clin Invest 2001; 107: 409-17. (Pubitemid 32167987)
10. Takikawa M, Nakamura S, Nakamura S, Ishirara M, et al. Enhanced effect of platelet-rich plasma containing a new carrier on hair growth. Dermatol Surg 2011; 37: 1721-9.
11. Li ZJ, Choi HI, Choi DK, Sohn KC, et al. Autologous platelet-rich plasma: a potential therapeutic tool for promoting hair growth. Dermatol Surg 2012; 38: 1040-6.
12. Rogers N. Commentary on autologous platelet-rich plasma: a potential therapeutic tool for promoting hair growth. Dermatol Surg 2012; 38: 1047-8.
13. Morris R, Liu Y, Marles L, Yang Z, et al. Capturing and profiling hair follicle stem cells. Nat Biotechnol 2004; 22: 411-7. (Pubitemid 38451371)
14. Garza LA, Yang CC, Zhao T, Blatt HB, et al. Bald scalp in men with androgenetic alopecia retains hair follicle stem cells but lacks CD200- rich and CD34-positive hair follicle progenitor cells. J Clin Invest 2011; 121: 613-22.
15. Paus R, Cotsarelis G. The biology of hair follicles. N Engl J Med 1999; 341: 491-7. (Pubitemid 29372890)
16. Nagata MJH, Messora MR, Furlaneto FAC, Fucini SE, et al. Effectiveness of two methods for preparation of autologous platelet-rich plasma: an experimental study in rabbits. Eur J Dent 2010; 4: 395-402.
17. Dhurat R, Saraogi P. Hair evaluation methods: merits and demerits. Int J Trichology 2009; 1: 108-19.
18. Saraogi PP, Dhurat RS. Automated digital image analysis (TrichoScan) for human hair growth analysis: ease versus errors. Int J Trichology 2010; 2: 5-13.
19. Van Neste D, Trüeb RM. Critical study of hair growth analysis with computer-assisted methods. J Eur Acad Dermatol Venereol 2006; 20: 578-83.
20. Jaeschke R, Singer J, Guyatt GH. Measurement of health status. Ascertaining the minimal clinically important difference. Control Clin Trials 1989; 10: 407-15. (Pubitemid 20025670)
21. Deyo RA, Diehr P, Patrick DL. Reproducibility and responsiveness of health status measures: statistics and strategies for evaluation. Control Clin Trials 1991; 12(suppl 4): 142S-58S.
22. Mazzocca AD, McCarthy MB, Chowaniec DM, Cote MP, et al. Plateletrich plasma differs according to preparation method and human variability. J Bone Joint Surg Am 2012; 94: 308-16.
23. Dohan Ehrenfest DM, Rasmusson L, Albrektsson T. Classification of platelet concentrates: from pure platelet-rich plasma (P-PRP) to leucocyte- and platelet-rich fibrin (L-PRF). Trends Biotechnol 2009; 27: 158-67.
24. Waters JH, Roberts KC. Database review of possible factors influencing point-of-care platelet gel manufacture. J Extra Corpor Technol 2004; 36: 250-4. (Pubitemid 39453161)
25. Eppley BL, Woodell JE, Higgins J. Platelet quantification and growth factor analysis from platelet-rich plasma: Implications for wound healing. Plast Reconstr Surg 2004; 114: 1502-8. (Pubitemid 40361959)
26. Kevy SV, Jacobson MS. Comparison of methods for point of care preparation of autologous platelet gel. J Extra Corpor Technol 2004; 36: 28-35. (Pubitemid 38392711)
27. Gonshor A. Technique for producing platelet-rich plasma and platelet concentrate: background and process. Int J Periodontics Restorative Dent 2002; 22: 547-57.
28. Han J, Meng HX, Tang JM, Li SL, et al. The effect of different platelet plasma concentrations on proliferation and differentiation of human periodontal ligaments cells in vitro. Cell Prolif 2007; 40: 241-52. (Pubitemid 46398819)
29. Choi BH, Zhu SJ, Kim BY, Huh JY, et al. Effect of platelet rich plasma (PRP) concentration on the viability and proliferation of alveolar bone cells, an in vitro study. Int J Oral Maxillofac Surg 2005; 34: 420-4.
30. Zimmermann R, Arnold D, Strasser E, Ringwald J, et al. Sample preparation technique and white cell content influence the detectable levels of growth factors in platelet concentrates. Vox Sang 2003; 85: 283-89. (Pubitemid 37522602)
31. Weibrich G, Kleis WK, Kunz-Kostomanolakis M, Loos AH, et al. Correlation of platelet concentration in platelet-rich plasma to the extraction method, age, sex, and platelet count of the donor. Int J Oral Maxillofac Implants 2001; 16: 693-9. (Pubitemid 33674670)
32. Marx RE. Platelet-rich plasma: evidence to support its use. J Oral Maxillofac Surg 2004; 62: 489-96. (Pubitemid 38451232)
33. Marx RE. Platelet-rich plasma (PRP): what is PRP and what is not PRP? Implant Dent 2001; 10: 225-8.
34. Haynesworth SE, Kadiyala S, Liang LN, Bruder SP. Mitogenic stimulation of human mesenchymal stem cells by platelet releasate suggests a mechanism for enhancement of bone repair by platelet concentrate. Transactions of the 48th Meeting of the Orthopedic Research Society. Rosemont, IL: Orthopedic Research Society; 2002; 27: 462.
35. Everts PA, van Zundert A, Schönberger JP, Devilee RJ, et al. What do we use: platelet-rich plasma or platelet-leukocyte gel? J Biomed Mater Res A 2008; 85: 1135-6. (Pubitemid 351717984)
36. Cieslik-Bielecka A, Gazdzik TS, Bielecki TM, Cieslik T. Why the platelet-rich gel has antimicrobial activity? Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007; 103: 303-5.
37. Moojen DJ, Everts PA, Schure RM, Overdevest EP, et al. Antimicrobial activity of platelet-leukocyte gel against Staphylococcus aureus. J Orthop Res 2008; 26: 404-10.
38. Dohan Ehrenfest DM, Choukroun J, Diss A, Dohan SL, et al. Plateletrich fibrin (PRF): a second-generation platelet concentrate: leucocyte activation: a new feature for platelet concentrates? Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006; 101: e51-5. (Pubitemid 43303803)
39. El-Sharkawy H, Kantarci A, Deady J, Hasturk H, et al. Platelet-rich plasma: growth factors and pro- and anti-inflammatory properties. J Periodontol 2007; 78: 661-9.
40. Werther K, Christensen IJ, Nielsen HJ. Determination of vascular endothelial growth factor (VEGF) in circulating blood: significance of VEGF in various leucocytes and platelets. Scand J Clin Lab Invest 2002; 62: 343-50.
41. Kawase T, Okuda K, Wolff LF, Yoshie H. Platelet-rich plasmaderived fibrin clot formation stimulates collagen synthesis in periodontal ligament and osteoblastic cells in vitro. J Periodontol 2003; 74: 858-64. (Pubitemid 36874119)
42. Dohan DM, Choukroun J, Diss A, Dohan SL, et al. Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part II: platelet-related biologic features. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006; 101: e45-50. (Pubitemid 43303802)
43. Clark RAF, Lanigan JM, DellaPelle P, Manseau E, et al. Fibronectin and fibrin provide a provisional matrix for epidermal cell migration during wound reepithelialization. J Invest Dermatol 1982; 79: 264-9. (Pubitemid 12005678)
44. Clark RA. Synergistic signaling from extra cellular matrix-growth factor complexes. J Invest Dermatol 2008; 128: 1354-5. (Pubitemid 351693220)
45. Macri L, Silverstein D, Clark RAF. Growth factor binding to the pericellular matrix and its importance in tissue engineering. Adv Drug Deliv Rev 2007; 59: 1366-81. (Pubitemid 350090013)
46. Folkman J. Angiogenesis. Annu Rev Med 2006; 57: 1-18. (Pubitemid 43261975)
47. Mansouri K, Mostafaei A, Mirshahi M, Mohammadi-Motlagh HR, et al. Human coagulated plasma as a natural and low cost matrix for in vitro angiogenesis. Iran Biomed J 2009; 13: 179-83.